ERBB2 and ovarian mucinous adenocarcinoma: HER2 amplification, with overexpression of the protein on the membrane of the tumor cells, is present in 15%–20% of mucinous carcinomas of the ovary (J. N. McAlpine et al. BMC Cancer, in press).